Clinical Trial Update: ARREST - A Phase I Study of SABR for Poly-metastatic Disease [NA]

View source ↗

Summary

The ARREST study, a Phase I trial of SABR for poly-metastatic disease, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Metastatic Cancer | NA | Status: COMPLETED